Brian Keil
Managing Partner @ Alumni Ventures
New York, United States
Brian Keil is a seed investor at Alumni Ventures in New York focused on Artificial Intelligence and Software. Brian Keil: Brian is a Managing Director and Founding Member of the Peacock Equity Fund, a joint initiative sponsored by GE Commercial Finance and NBC Universal. He Prior to joining the Peacock Fund, Brian was a Senior Vice President at GE Equity for 8 years where he led a number of transactions in the enterprise software, business services, andmedia sectors. Brian received a B.S. in Industrial Engineering from the University of Southern California and an M.B.A. from the Wharton School.
- Total investments:
- 61
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries Brian Keil invests in
Stages Brian Keil invests in
Countries Brian Keil invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Artificial Intelligence 20 (33%)
- Software 14 (23%)
- Health Care 7 (11%)
- Information Technology 7 (11%)
- Semiconductor 5 (8%)
Stage
- Seed 18 (30%)
- Series A 11 (18%)
- Series B 11 (18%)
- Venture - Series Unknown 5 (8%)
- Series C 4 (7%)
Country
- United States 41 (67%)
- Australia 3 (5%)
- United Kingdom 2 (3%)
- Israel 1 (2%)
- Singapore 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NODA AI builds defense focused algorithm using software for collaborative autonomous systems. | $25M / Series A / Feb 26, 2026 | ||
| Neurophos develops photonic AI processing technology that focuses on hardware solutions for accelerating artificial intelligence inference by replacing traditional electronic compute elements with optical processing units (OPUs). The company’s technology uses ultra-dense optical modulators and silicon photonics to enable computation using light,aiming to support matrix operations central to AI workloads with increased energy efficiency and performance relative to conventional graphics processing units. Neurophos’ offerings include prototype OPUs and development systems designed to integrate into data center environments, and its platform targets engineering teams and compute-intensive applications that demand scalable AI inference capability. The business collaborates with industry partners and investors to advance its optical compute architecture and develop supporting software stacks and hardware modules for deployment. Neurophos also engages in pilot programs and partnerships to test its photonic processors in real-world compute environments and explore integration pathways with existing infrastructure. Its work leverages research in metamaterials and compute-in-memory design to reduce power consumption and enhance throughput for AI inference tasks. | $110M / Series A / Jan 22, 2026 | ||
| Haiqu Inc. is a quantum computing software firm focusing on the development of enabling technology to improve the performance of modern quantum hardware. Their software addresses the adoption obstacles that prevent scalable quantum applications from being realized, allowing for a broader variety of practical use cases in finance, life sciences,mobility, and other fields. | $11M / Seed / Jan 13, 2026 | ||
| The Iambic AI-driven platform was created to address the most challenging design problems in drug discovery, leveraging technology innovations such as Enchant, a multi-modal transformer model that predicts clinical outcomes from the earliest stages of discovery, and NeuralPLexer, the best-in-class predictor of protein and protein-ligand structures.The integration of physics principles into the platform’s AI architectures improves data efficiency and allows molecular models to venture widely across the space of possible chemical structures. The platform enables identification of novel chemical modalities for engaging difficult-to-address biological targets, discovery of defined product profiles that optimize therapeutic window, and multi-parameter optimization for highly differentiated development candidates. Through close integration of AI-generated molecular designs with automated experimental execution, Iambic completes design-make-test cycles on a weekly cadence. | $127.8M / Nov 10, 2025 | ||
| Heidi Health develops an ambient AI medical scribe platform that automates clinical documentation and related tasks. It listens to patient-clinician conversations, transcribes key highlights, and then produces structured notes, referral letters, patient summaries, billing codes, and other downstream documents. The system supports customizabletemplates, allows editing during sessions, and integrates with various EHR systems while offering compliance with privacy and security standards. Clinicians in multiple specialties and care settings use Heidi to reduce administrative burden, improve focus on patient care, and streamline workflows. | $65M / Series B / Oct 06, 2025 | ||
| F2 AI offers an AI platform specifically designed for private markets, including private finance, private equity, and commercial banking. | $10M / Seed / Sep 16, 2025 | ||
| Observe is an observability platform built on a streaming data lake for faster search and correlation at a lower cost. The company uses an O11y Knowledge Graph to structure logs, metrics, and traces as entities with semantic relationships. It also uses O11y AI to help resolve incidents faster and reduce costs. | $156M / Series C / Jul 30, 2025 | ||
| Teramount changes the world of silicon photonics by offering a novel solution, the patent-pending Photonic-Plug, for connecting optics to silicon.Teramount Photonic-Plug enables standard semiconductor manufacturing processes and packaging flow in silicon photonics, thus enables any fabless semiconductor company to expand into silicon photonicswhile working with traditional foundries and OSATs. | $50M / Series A / Jul 29, 2025 | ||
| Avalanche is a decentralized platform designed for building scalable applications and custom blockchain networks. | Series A / Jul 11, 2025 | ||
| Pano offers hardware and software technology solutions for fire professionals to detect threats. Pano provides tools to the government, utilities, insurers, and private landowners in order to mitigate wildfire threats and protect lives, property, and the environment. Pano is a unified enterprise solution that combines cutting-edge hardware,artificial intelligence, and software. | $44M / Series B / Jun 16, 2025 | ||
| See all 61 investments → | |||
Co-Investors
About Alumni Ventures
Alumni Ventures identifies and co-invests in deals alongside various established venture capital firms across multiple stages, from pre-seed to later-stage growth. Investors can participate through annual funds containing multiple companies or via a syndicate for individual deal-by-deal selections. The firm maintains several distinct investmentteams that evaluate opportunities across sectors such as artificial intelligence, healthcare, and strategic technology.
Alumni Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Aaron Sandford
Graphic Designer
|
|||
|
Alea Capello
'People and Culture, Associate
|
|||
|
Alexandra Critch
Product Manager Lead MarTec
|
|||
|
Alex Ovabor
VenturesCorps Analyst
|
|||
|
Allison Newman
Paralegal, Compliance Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Brian Keil invest in?
Brian Keil invests primarily in Artificial Intelligence, Software and Health Care startups, most often at Seed and Series A stage. Most of the 61 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Brian Keil?
Public channels for Brian Keil include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Brian Keil last invest?
The most recent investment recorded for Brian Keil closed in Feb 2026. Shizune tracks 61 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
